ATRASENTAN IN PATIENTS WITH PROTEINURIC GLOMERULAR DISEASES- THE AFFINITY STUDY
Back
Abstract Number
WCN23-1117
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
ATRASENTAN IN PATIENTS WITH PROTEINURIC GLOMERULAR DISEASES- THE AFFINITY STUDY
Co-authors
Kim, S.G.(1)*;Akinfolarin, A.A.(2);Inker, L.A.(3);Lafayette, R.(4);Pedagogos, E.(5);Rheault, M.N.(6);Tumlin, J.(7,8);DeVries, T.(9);Sheth, K.(10);Camargo, M.(10);King, A.J.(11);Jones-Burton, C.(10);Han, S.H.(12);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Hallym University Sacred Heart Hospital, Nephrology Division, Gyeonggi-do, South Korea;(2)Dallas Nephrology Associates, Nephrology, Dallas, United States;(3)Tufts Medical Center, Clinical and Translational Science, Boston, United States;(4)Stanford University, Division of Nephrology, Stanford, United States;(5)Sunshine Hospital, Nephrology, St Albans, Australia;(6)University of Minnesota, Division of Pediatric Nephrology, Minneapolis, United States;(7)NephroNet Clinical Trials Consortium, Nephrology, Atlanta, United States;(8)Emory University School of Medicine, Department of Medicine, Atlanta, United States;(9)Chinook Therapeutics- Inc, Biometrics, Seattle, United States;(10)Chinook Therapeutics- Inc, Clinical Development, Seattle, United States;(11)Chinook Therapeutics- Inc, Biology, Seattle, United States;(12)Yonsei University College of Medicine, Division of Nephrology, Seoul, South Korea;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/3383aea9e3402d20b221e204eb456c43.pdf
Audio File
if any